These results are consistent with another recent study showing that pharmacological inhibition of LRRK2 kinase in WT neurons increases anterograde transport of alpha-synuclein, a presynaptic protein that aggregates in PD and is thought to play a physiological role in regulating neurotransmitter release [74]. Here, SNCA is linked to Parkinson disease.